BRIEF published on 12/17/2025 at 09:10, 7 months 12 days ago Norgine Secures Licensing Deal with Vir Biotechnology for Hepatitis Delta Treatment Pharmaceuticals Licensing Agreement Norgine Vir Biotechnology Hepatitis Delta
PRESS RELEASE published on 12/17/2025 at 09:05, 7 months 12 days ago Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology Norgine enhances hepatology and specialty portfolio by in-licensing Vir Biotechnology's chronic hepatitis delta treatment for Europe, Australia, and New Zealand Exclusive Licensing Agreement Specialty Pharmaceuticals Norgine Vir Biotechnology Chronic Hepatitis Delta Treatment
Published on 07/30/2026 at 04:10, 1 hour 45 minutes ago Pathfinder Ventures Announces Appointment of Mark Roseborough as Chief Executive Officer
Published on 07/30/2026 at 01:50, 4 hours 5 minutes ago Further Assays Infill Tunkillia Pit Extension Targets
Published on 07/30/2026 at 00:50, 5 hours 5 minutes ago Aton Announces Strategic Cooperation Relationship and Board Nominee
Published on 07/30/2026 at 00:00, 5 hours 55 minutes ago American Hotel Income Properties REIT LP to Host Second Quarter 2026 Results Conference Call on August 6, 2026
Published on 07/29/2026 at 23:01, 6 hours 54 minutes ago Blueberries Medical Announces C$1.1 Million Non-Brokered Private Placement
Published on 07/29/2026 at 21:45, 8 hours 10 minutes ago Piramal Pharma Limited Announces Results for Q1 FY27
Published on 07/29/2026 at 21:12, 8 hours 42 minutes ago Interim individual report for the period ending on 30.06.2026
Published on 07/29/2026 at 18:25, 11 hours 30 minutes ago International Fencing Federation prevails over Reuters in court - Court of Appeal prohibits false claims about the open letter to the IOC
Published on 07/29/2026 at 18:21, 11 hours 33 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/29/2026 at 18:07, 11 hours 47 minutes ago Quarterly Activities Report for the period ending 30 June 2026
Published on 07/29/2026 at 23:00, 6 hours 55 minutes ago BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Published on 07/29/2026 at 18:40, 11 hours 14 minutes ago Aéroports de Paris SA - Availability of the 2026 financial interim report
Published on 07/29/2026 at 18:30, 11 hours 25 minutes ago Aéroports de Paris SA - Groupe ADP 2027-2034 Economic Regulation Agreement (ERA) project
Published on 07/29/2026 at 18:29, 11 hours 26 minutes ago Aéroports de Paris SA - 2026 Half-year results
Published on 07/29/2026 at 17:54, 12 hours 1 minute ago Availability of the half-year financial report for 2026
